Nabiha Saklayen, Cellino co-founder and CEO (via Cellino)
January 25, 2022 09:25 AM ESTUpdated June 28, 01:44 PM
Financing
Startups
Pharma
Manufacturing

Backed by Bay­er's Leaps, Boston-based Celli­no lands $80M for cell ther­a­py-in-box

Josh Sullivan

The sum­mer be­fore Celli­no CEO and co-founder Nabi­ha Sak­layen start­ed at Har­vard, she lost her grand­moth­er fol­low­ing com­pli­ca­tions to di­a­betes. Be­fore then, she hadn’t tak­en …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times